Data on Bacillus Calmette-Guerin Vaccines Discussed by Researchers at Sun Yat Sen Zhongshan University (Intravesical Pseudomonas Aeruginosa Mannose-sensitive Hemagglutinin Vaccine Triggers a Tumor-preventing Immune Environment In an Orthotopic...).

Keywords: Guangzhou; People's Republic of China; Asia; BCG Therapy; BCG Vaccines; Bacillus Calmette-Guerin (BCG); Bacillus Calmette-Guerin Vaccines; Bacterial Vaccines; Biological Products; Bladder Cancer; Cancer; Drugs and Therapies; Gammaproteobacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci; Gram-Negative Bacteria; Health and Medicine; Immunization; Immunization and Public Health; Immunology; Oncology; Proteobacteria; Pseudomonadaceae; Pseudomonas; Pseudomonas aeruginosa; Tuberculosis Vaccines; Vaccines EN Guangzhou People's Republic of China Asia BCG Therapy BCG Vaccines Bacillus Calmette-Guerin (BCG) Bacillus Calmette-Guerin Vaccines Bacterial Vaccines Biological Products Bladder Cancer Cancer Drugs and Therapies Gammaproteobacteria Gram-Negative Aerobic Bacteria Gram-Negative Aerobic Rods and Cocci Gram-Negative Bacteria Health and Medicine Immunization Immunization and Public Health Immunology Oncology Proteobacteria Pseudomonadaceae Pseudomonas Pseudomonas aeruginosa Tuberculosis Vaccines Vaccines 34 34 1 08/21/23 20230821 NES 230821 2023 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Investigators discuss new findings in Immunization and Public Health - Bacillus Calmette-Guerin Vaccines. A commercial anti-infection vaccine comprises a genetically engineered heat-killed Pseudomonas aeruginosa (PA) expressing many mannose-sensitive hemagglutination (MSHA) fimbriae, termed PA-MSHA, which could be a candidate for bladder cancer intravesical therapy.". [Extracted from the article]